Johan A. Maertens

Johan A. Maertens

Transplant Surgery

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 558 publications

Re: 'Novel antifungal agents for the management of invasive mould disease' by Vuong et al.

Re: 'Novel antifungal agents for the management of invasive mould disease' by Vuong et al.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: May 13, 2026

Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable- and intermediate-risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials.

Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable- and intermediate-risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials.

Journal: HemaSphere

Published: April 21, 2026

Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim.

Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim.

Journal: Antimicrobial agents and chemotherapy

Published: April 20, 2026

Detection of Galactofuranose-Containing Antigens Associated With Aspergillus Extracellular Vesicles in Urine: The Biological Basis of a New Diagnostic for Aspergillosis.

Detection of Galactofuranose-Containing Antigens Associated With Aspergillus Extracellular Vesicles in Urine: The Biological Basis of a New Diagnostic for Aspergillosis.

Journal: The Journal of infectious diseases

Published: March 31, 2026

Diagnosis and risk factors for invasive mould disease-a round table discussion on directing antifungal therapy according to the available evidence.

Diagnosis and risk factors for invasive mould disease-a round table discussion on directing antifungal therapy according to the available evidence.

Journal: The Journal of antimicrobial chemotherapy

Published: March 14, 2026

Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry-Based Study on Behalf of the Chronic Malignancies Working of the EBMT.

Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry-Based Study on Behalf of the Chronic Malignancies Working of the EBMT.

Journal: American journal of hematology

Published: March 09, 2026

25 years of improvement in mortality in invasive aspergillosis in haematology patients: will it be sustained or is it under threat?

25 years of improvement in mortality in invasive aspergillosis in haematology patients: will it be sustained or is it under threat?

Journal: The Journal of antimicrobial chemotherapy

Published: March 06, 2026

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

Journal: HemaSphere

Published: February 26, 2026

Rapid and reliable diagnosis of mucormycosis using colorimetric loop-mediated isothermal amplification.

Rapid and reliable diagnosis of mucormycosis using colorimetric loop-mediated isothermal amplification.

Journal: Journal of clinical microbiology

Published: February 26, 2026

Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

Journal: American journal of hematology

Published: February 03, 2026

Author Correction: Albumin orchestrates a natural host defence mechanism against mucormycosis.

Author Correction: Albumin orchestrates a natural host defence mechanism against mucormycosis.

Journal: Nature

Published: February 02, 2026

Liposomal amphotericin B and renal safety: review of the evidence and clinical considerations.

Liposomal amphotericin B and renal safety: review of the evidence and clinical considerations.

Journal: The Journal of antimicrobial chemotherapy

Published: January 19, 2026

Showing 1-12 of 558

Last Updated: 09/26/2026